Location History:
- Omaha, AR (US) (2001 - 2002)
- Omaha Park, AR (US) (1999 - 2004)
- Lenexa, KS (US) (1995 - 2006)
- Nashville, TN (US) (2006)
Company Filing History:
18 out of 548 
8 out of 10 
4 out of 1,327 
Years Active: 1995-2006
Title: Billy G. Hudson: Innovator in Biomedical Research
Introduction
Billy G. Hudson, based in Lenexa, Kansas, is a prominent inventor with an impressive portfolio of 29 patents. His contributions primarily focus on advancements in biomedical research, particularly in the fields of collagen structure and diabetes treatment. His innovative work has led to significant breakthroughs that have the potential to impact medical science and patient care.
Latest Patents
Among Hudson's latest inventions is a patent for the crystallized structure of the type IV collagen NC1 domain hexamer. This invention provides a detailed method for creating a crystallized NC1 domain hexamer of Type IV collagen, enabling the determination of its three-dimensional structure with a resolution of at least 3 Å or better. Such information is crucial in the design of compounds aimed at inhibiting angiogenesis, tumor growth, tumor metastasis, and other related medical issues. Furthermore, Hudson has developed methods for treating diabetic neuropathy through the administration of pyridoxamine or its salts, offering new hope for those affected by this condition.
Career Highlights
Billy G. Hudson has had an influential career, primarily associated with the University of Kansas Medical Center and Kansas University Medical Center. His innovations reflect a deep understanding of complex biochemical processes and a commitment to addressing critical health challenges. His extensive research has positioned him as a key figure in the field of biomedical innovation.
Collaborations
Throughout his career, Hudson has collaborated with notable colleagues such as Michael P. Sarras, Jr. and Raja Gabriel Khalifah. These partnerships have not only enhanced his research capabilities but also contributed to the advancement of knowledge in their respective fields.
Conclusion
Billy G. Hudson's work exemplifies the spirit of innovation in the biomedical sector. With a substantial number of patents, his contributions encompass vital advancements in understanding collagen structures and treating diseases like diabetic neuropathy. His ongoing research and collaborations continue to pave the way for future developments that could transform healthcare approaches and outcomes.